Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropathy in GAA-FGF14 Late-Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics.
Theuriet J, Paulet L, Acket B, Ory-Magne F, Belbachir H, Chanson JB, Bouhour F, Laurencin C, Froment Tilikete C, Lardeux P, Clement G, Hocquel A, Renaud M, Bonnet C, Marelli C, Weber S, Comet C, Azulay JP, Fluchère F, Coarelli G, Heinzmann A, Ewenczyk C, Verny C, Guillet-Pichon V, Guyant-Marechal L, Desjardins C, Riou A, Degos B, Mercier S, Goizet C, Degoutin M, Angelini C, Laurens B, Degardin A, Carrière N, Le Guyader G, Schneider V, Dupont G, Thomas Q, Merindol M, Besse-Pinot E, Méneret A, Roze E, Durr A, Thobois S, Anheim M, Wirth T, Pegat A. Theuriet J, et al. Among authors: weber s. Eur J Neurol. 2025 Jul;32(7):e70247. doi: 10.1111/ene.70247. Eur J Neurol. 2025. PMID: 40579842
Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis.
Ueberall L, Mohammadian H, Demmler R, Ariza Y, Tripal P, Anchang CG, Weber S, Angeli MR, Raimondo MG, Chang J, Huang K, Distler JHW, Distler O, Rauber S, Schett G, Ramming A, Ramming AM. Ueberall L, et al. Among authors: weber s. Ann Rheum Dis. 2025 Jun 26:S0003-4967(25)01025-8. doi: 10.1016/j.ard.2025.05.016. Online ahead of print. Ann Rheum Dis. 2025. PMID: 40579317
The feasibility of respondent-driven sampling with people who use drugs in rural Western Cape, South Africa: A qualitative study.
Carney T, Johnson K, Meade C, Niemand N, Rooney J, Weber S, Lambrechts T, Mpisane N, Horsburgh CR, Theron D, Warren R, Thomson S, Overbeck V, Myers B, Jacobson K. Carney T, et al. Among authors: weber s. PLOS Glob Public Health. 2025 Jun 26;5(6):e0004065. doi: 10.1371/journal.pgph.0004065. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40569934 Free PMC article.
[Basic knowledge of drug pain therapy in the palliative situation].
Weber S, Lampert A, Stingl JC, Peuckmann-Post V, Hiddemann S, Elsner F, Neuner I, Rolke R. Weber S, et al. Dtsch Med Wochenschr. 2025 Jul;150(14):817-825. doi: 10.1055/a-2544-4239. Epub 2025 Jun 25. Dtsch Med Wochenschr. 2025. PMID: 40562057 Review. German.
Oligoclonal banding analysis: assessing plasma use and time interval requirements for paired CSF and blood.
Olayinka L, Chen Y, Rodriguez-Capote K, Gifford JL, Buch C, Weber S, Parker ML, Volodko N, Estey MP, Proctor D, Newbigging A, Bordeleau P, Powell M, Beriault DR, Macri J, Higgins V. Olayinka L, et al. Among authors: weber s. Clin Chem Lab Med. 2025 Jun 26. doi: 10.1515/cclm-2025-0649. Online ahead of print. Clin Chem Lab Med. 2025. PMID: 40560807 No abstract available.
BioBone - A prospective, blinded, multicenter validation study of the CD8 + terminal differentiated effector memory cells (CD8 + TEMRA cells) as prognostic biomarker for disturbed fracture healing - study design.
Reinke S, Bauer AM, Dahne M, Duda G, Gümbel D, Kleber C, Matziolis G, Märdian S, Osterhoff G, Perka C, Raschke MJ, Rohe S, Schaser KD, Schwabe P, Schäfer FM, Stange R, Stiehler M, Stöckle U, Volk HD, Weber S, Geißler S; BioBone Author Consortium. Reinke S, et al. Among authors: weber s. J Orthop Surg Res. 2025 Jun 16;20(1):594. doi: 10.1186/s13018-025-05987-7. J Orthop Surg Res. 2025. PMID: 40524198 Free PMC article.
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Taylor KI, Lipsmeier F, Scelsi MA, Volkova-Volkmar E, Rukina D, Popp W, Lambrecht S, Anzures-Cabrera J, Summers D, Abt M, Monnet A, Kilchenmann T, Schjodt-Eriksen J, Essioux L, Kustermann T, Zago W, Svoboda H, Nikolcheva T, Postuma RB, Pagano G, Lindemann M; PASADENA Investigators; Prasinezumab Study Group. Taylor KI, et al. NPJ Digit Med. 2025 Jun 16;8(1):365. doi: 10.1038/s41746-025-01572-8. NPJ Digit Med. 2025. PMID: 40523921 Free PMC article.
3,728 results